United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for COMPUGEN LTD? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -23.63% | -8.6% | -7.61% | -11.89% | -15.77% | -19.62% |
|---|---|---|---|---|---|---|
| ROA | -12.04% | -3.81% | -2.91% | -3.87% | -4.18% | -4.07% |
| Gross Margin | 71.54% | 68.83% | 68.23% | 67.84% | 67.04% | 67.14% |
| Net Margin | -51.07% | -14.18% | -10.68% | -13.6% | -14.63% | -14.2% |
| Total Assets | $114,995.00K | $122,736.28K | $131,096.86K | $140,126.29K | $149,878.07K | $160,410.00K |
| Net Income | -$14,231.00K | -$4,527.89K | -$3,693.71K | -$5,242.26K | -$6,059.78K | -$6,322.10K |